Trends in the introduction of new drugs by pharmaceutical firms.

被引：0

作者：

DiMasi, JA ^{[1
]}

Healy, EM ^{[1
]}

Lasagna, L ^{[1
]}

机构：

[1] Tufts Univ, Tufts Ctr Study Drug Dev, Boston, MA 02111 USA

来源：

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

PI34

引用

下载

页码：145 / 145

页数：1

共 50 条

[41] At the heart of auditing and consulting firms. From distinction to submission
Coblence, Emmanuel
Deschaintre, Stephane
RELATIONS INDUSTRIELLES-INDUSTRIAL RELATIONS, 2019, 74 (01): : 198 - 200
[42] Organizational sustainability and career frameworks in professional services firms.
Ribes, Edouard
ECONOMICS BULLETIN, 2020, 40 (01): : 880 - 889
[43] Bustup takeovers of value-destroying diversified firms.
Berger, PG
Ofek, E
JOURNAL OF FINANCE, 1996, 51 (03): : 1026 - 1027
[44] The dynamic familiness of family firms. The case of Grupo Yllera
Barros-Contreras, Ismael
Hernangomez-Barahona, Juan
Martin-Cruz, Natalia
UNIVERSIA BUSINESS REVIEW, 2014, (42): : 88 - 109
[45] INTRODUCTION OF NEW DRUGS
不详
JOURNAL OF THE AMERICAN PHARMACEUTICAL ASSOCIATION-PRACTICAL PHARMACY EDITION, 1946, 7 (02): : 52 - 52
[46] INTRODUCTION OF NEW DRUGS
FRANKFORD, RT
CANADIAN MEDICAL ASSOCIATION JOURNAL, 1975, 113 (11-1) : 1022 - 1022
[47] INTRODUCTION OF NEW DRUGS
WILSON, GSL
CANADIAN MEDICAL ASSOCIATION JOURNAL, 1975, 112 (05) : 555 - 556
[48] Administrative Fragmentation and Productivity of Firms. Case Study: Slovakia
Cernenko, Tomas
Peciar, Vladimir
CURRENT TRENDS IN PUBLIC SECTOR RESEARCH, 2019, : 66 - 75
[49] INTRODUCTION OF NEW DRUGS
MORRISON, AB
CANADIAN MEDICAL ASSOCIATION JOURNAL, 1975, 112 (11) : 1285 - &
[50] SURVEY OF HAZARDOUS LIABILITIES FOR PRACTICING CIVIL ENGINEERING FIRMS.
Tusa, Wayne
Journal of Management in Engineering, 1987, 3 (02) : 90 - 94